DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles

This publication has 23 references indexed in Scilit:

• Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
• Characteristics of Gastrointestinal Absorption of DX-9065a, a New Synthetic Anticoagulant
  Drug Metabolism and Pharmacokinetics, 2007
• First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
  Journal of Thrombosis and Haemostasis, 2004
• Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa
  Biochemical Pharmacology, 2003
• Antithrombotic Effects of DX-9065a, a Direct Factor Xa Inhibitor
  Thrombosis and Haemostasis, 2002
• State-of-the-Art Review: Anticoagulation: The Present and Future
  Clinical and Applied Thrombosis/hemostasis, 2001
• Low-Molecular-Weight Heparins
  New England Journal of Medicine, 1997
• Antithrombotic and Hemorrhagic Effects of DX-9065a, a Direct and Selective Factor Xa Inhibitor: Comparison with a Direct Thrombin Inhibitor and Antithrombin Ill-Dependent Anticoagulants
  Thrombosis and Haemostasis, 1997
• The coagulation cascade: initiation, maintenance, and regulation
  Biochemistry, 1991
• Heparin
  New England Journal of Medicine, 1991